<\/p>\n
Glisen PM<\/strong> je triple-drug fixed-dose combination<\/strong> z glimepiride, pioglitazone and metformin<\/strong> (Glimepiride 1 mg (or 2 mg) + Pioglitazone 15 mg + Metformin 500 mg) used for diabetu 2. typu<\/strong> not controlled on dual therapy. It targets hyperglycaemia through three complementary mechanisms: glimepiride stimulates insulin release from the pancreas, pioglitazone reduces insulin resistance in muscle\/fat\/liver, and metformin reduces liver glucose output. Typical HbA1c reduction: 2.0–2.5 points<\/strong>. Usual dose: one tablet once daily with breakfast. Side-effect profile combines hypoglycaemia risk (from glimepiride), weight gain and oedema (from pioglitazone), and metformin GI upset. Avoid in heart failure, active bladder cancer, eGFR < 30, severe hepatic impairment, and sulfa allergy. This is typically a step before insulin initiation.<\/p>\n<\/div>\n \ud83d\udce6 Ka\u017ed\u00e1 objedn\u00e1vka je pokryta na\u0161\u00ed Z\u00e1rukou op\u011btovn\u00e9ho odesl\u00e1n\u00ed<\/strong><\/a> \u2014 pokud va\u0161e z\u00e1silka nedoraz\u00ed do 20 pracovn\u00edch dn\u016f, p\u0159epos\u00edl\u00e1me ji.<\/p>\n Na\u0161e generick\u00e9 l\u00e9ky poch\u00e1zej\u00ed od v\u00fdrobc\u016f certifikovan\u00fdch WHO-GMP a jsou expedov\u00e1ny po cel\u00e9m sv\u011bt\u011b v diskr\u00e9tn\u00edm, nen\u00e1padn\u00e9m balen\u00ed \u2013 na vn\u011bj\u0161\u00ed stran\u011b bal\u00edku nen\u00ed uveden n\u00e1zev l\u00e9ku. Platby kartou jsou sm\u011brov\u00e1ny prost\u0159ednictv\u00edm regulovan\u00e9ho procesoru (popisky na v\u00fdpisu zahrnuj\u00ed regulovan\u00e9ho procesora plateb kartou \u2013 nikdy \u201cMedsBase\u201d nebo n\u00e1zev l\u00e9ku). P\u0159ij\u00edm\u00e1me tak\u00e9 kryptom\u011bny a bankovn\u00ed p\u0159evody SEPA. Ka\u017ed\u00e1 objedn\u00e1vka je zaji\u0161t\u011bna na\u0161\u00ed politikou p\u0159eposl\u00e1n\u00ed.<\/p>\n Glisen PM is an oral fixed-dose combination tablet containing three active antidiabetic ingredients: glimepiride, pioglitazone and metformin hydrochloride<\/strong> (Glimepiride 1 mg (or 2 mg) + Pioglitazone 15 mg + Metformin 500 mg). It is manufactured by WHO-GMP certified manufacturer and supplied in packs of 30, 60, 90 or 180 tablets.<\/p>\n Triple therapy in a single tablet is used when dual therapy (usually metformin + sulfonylurea or metformin + TZD) is not achieving glycaemic targets, and the clinician wants to intensify treatment without starting insulin yet.<\/p>\n The three components attack hyperglycaemia from three different directions:<\/p>\n Combined HbA1c reduction is typically 2.0–2.5 percentage points<\/strong> compared with dual therapy.<\/p>\n Obvykl\u00e1 d\u00e1vka:<\/strong> one tablet once daily, with or just before breakfast. Some prescribers use one tablet twice daily with larger meals if HbA1c is not controlled on once-daily dosing.<\/p>\n \u010cast\u00e9:<\/strong><\/p>\n Vz\u00e1cn\u00e9, ale z\u00e1va\u017en\u00e9:<\/strong> severe hypoglycaemia (especially in older adults, renal impairment); heart failure decompensation; bladder cancer (long-term high-dose pioglitazone); macular oedema; bone fracture in women; lactic acidosis (very rare; acute kidney injury or hypoxia).<\/p>\n In older adults (> 65):<\/strong> triple therapy containing a sulfonylurea carries a high hypoglycaemia risk. Many clinicians prefer a DPP-4 inhibitor or SGLT-2 inhibitor instead of glimepiride in this group.<\/p>\n Store Glisen PM below 30°C in a dry place. Keep out of reach of children.<\/p>\n Usually when dual therapy (typically metformin + sulfonylurea, or metformin + TZD) is not achieving HbA1c targets, and the clinician wants to intensify oral therapy before starting insulin. It is also convenient for patients already taking these three medicines separately — one tablet instead of three improves adherence.<\/p>\n Clinically, yes — same molecules at the same doses. The fixed-dose combination improves adherence and typically costs less, but offers less flexibility if one component needs a dose change.<\/p>\n Yes — it contains glimepiride, a sulfonylurea. Skipping meals, unusual exercise, alcohol without food, and renal impairment all raise hypoglycaemia risk. Always take with food and carry glucose tablets.<\/p>\n Typically 2–4 kg over the first year — driven by pioglitazone (fluid and fat redistribution) and glimepiride (anabolic effect of more insulin). Metformin partially offsets this. Diet and exercise are the best counterweights.<\/p>\n That is a decision for you and your prescriber. Insulin gives more predictable glucose control and is essential once beta-cell reserve is exhausted, but it requires injections and has its own hypoglycaemia and weight-gain profile. Triple oral therapy is often tried first in motivated patients who want to avoid injections.<\/p>\n You can order Glisen PM (Glimepiride 1 mg (or 2 mg) + Pioglitazone 15 mg + Metformin 500 mg) from MedsBase in packs of 30, 60, 90 or 180 tablets. We ship worldwide, with discreet packaging and genuine WHO-GMP certified manufacturer stock.<\/p>\n <\/p>\n Dal\u0161\u00ed produkty v Chronick\u00e1 onemocn\u011bn\u00ed<\/strong> kter\u00e9 z\u00e1kazn\u00edci tak\u00e9 prohl\u00ed\u017eej\u00ed:<\/p>\n \u2705 Reguluje hladinu cukru v krvi Glisen PM contains Glimepiride, Metformin, and Pioglitazone.<\/p>","protected":false},"featured_media":57403,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3230,3231],"product_tag":[3251,4296,3255,4297],"class_list":{"0":"post-57402","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-diabetes","9":"product_cat-diabetes-medication","10":"product_tag-glimepiride","11":"product_tag-glisen-pm","12":"product_tag-metformin","13":"product_tag-pioglitazone","15":"first","16":"instock","17":"shipping-taxable","18":"purchasable","19":"product-type-variable","20":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product\/57402","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/comments?post=57402"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media\/57403"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/media?parent=57402"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_brand?post=57402"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_cat?post=57402"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/cs\/wp-json\/wp\/v2\/product_tag?post=57402"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Pro\u010d objedn\u00e1vat z MedsBase<\/h3>\n
What Is Glisen PM?<\/h2>\n
How Does Glisen PM Work?<\/h2>\n
\n
D\u00e1vkov\u00e1n\u00ed a pod\u00e1n\u00ed<\/h2>\n
\n
Vedlej\u0161\u00ed \u00fa\u010dinky<\/h2>\n
\n
Interakce s l\u00e9\u010divy<\/h2>\n
\n
Who Should Not Take Glisen PM?<\/h2>\n
\n
Skladov\u00e1n\u00ed<\/h2>\n
\u010casto kladen\u00e9 dotazy<\/h2>\n
When is a triple-drug diabetes tablet like Glisen PM prescribed?<\/h3>\n
Is Glisen PM the same as taking the three drugs separately?<\/h3>\n
Will Glisen PM cause low blood sugar?<\/h3>\n
How much weight will I gain on Glisen PM?<\/h3>\n
Should I switch to insulin instead?<\/h3>\n
Where can I buy Glisen PM online?<\/h3>\n
Souvisej\u00edc\u00ed l\u00e9ky na diabetes<\/h2>\n
\n
Souvisej\u00edc\u00ed alternativy<\/h3>\n
\n
\n\u2705 Controls diabetes
\n\u2705 Zlep\u0161uje citlivost na inzul\u00edn
\n\u2705 Reduces glucose levels
\n\u2705 Zlep\u0161uje kontrolu glyk\u00e9mie<\/p>\n